On March 18, 2024, Mind Medicine (MindMed) Inc. closed the transaction. The company will issue securities pursuant to exemption provided under Regulation D from two investors.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.01 USD | -6.24% | -5.46% | +145.90% |
08/05 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Mind Medicine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+145.90% | 691M | |
+24.77% | 46.71B | |
+48.83% | 41.8B | |
-1.09% | 41.52B | |
-5.86% | 29.55B | |
+10.86% | 25.78B | |
-20.42% | 19.26B | |
+2.44% | 12.14B | |
-3.68% | 12.08B | |
+28.95% | 11.98B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Mind Medicine Inc. announced that it has received $75 million in funding from Deep Track Capital, LP, Commodore Capital